Prof. Edouard
Kouassi
University
of Montreal, Canada
Email: edouard.kouassi@umontreal.ca
Qualifications
1990 Ph.D.,
University Claude-Bernard, Lyon-1, Pharmaceutical Sciences
1985 Ph.D.,
University of Montreal, Pharmacology
1982 M.Sc.,
University Claude-Bernard, Lyon-1, Immunology
1981 M.Sc.,
University of Montreal, Pharmacology
1979 B.Sc.,
Pharmacy, University of Montreal
Publications (Selected)
1. McIntyre A, Paisley D, Kouassi E, Gendron
A. Quetiapine fumarate extended-release for the treatment of major depression
with comorbid fibromyalgiasyndrome: a double-blind, randomized,
placebo-controlled study. Arthritis&Rheumatology 66:451-461, 2014.
2. Vincent PD, Kouassi E. Efficacy of
antipsychotic drugs for schizophrenia. The Lancet 382:1873-1874, 2013.
3. Tourjman V, Kouassi É, Koué MÈ, Rocchetti
M, Fortin-Fournier S, Fusar-Poli P, Potvin S. Antipsychotics' effects on blood
levels of cytokines in schizophrenia: a meta-analysis. Schizophrenia Research
151:43-47, . 2013.
4. Desfossés J, Stip E, Bentaleb LA, Lipp O,
Chiasson JP, Furtos A, Venne K, Kouassi E, Potvin S. Plasma Endocannabinoid
Alterations in Individuals with Substance Use Disorder are Dependent on the
"Mirror Effect" of Schizophrenia. Frontiers in Psychiatry 3:85, 2012.
5. Tourjman, SV, Koué, ME, Kouassi, E, Potvin,
S. In vivo immunomodulatory effects of antipsychotics on inflammatory
mediators: a review. Advances in Bioscience and Biotechnology Vol. 3 No. 4A,
2012.
6. Igue R, Potvin S, Bah R, Stip E, Bouchard
RH, Lipp O, Gendron A, Kouassi E. Soluble interleukin-2 receptor levels
correlated with positive symptoms during quetiapine treatment in schizophrenia.
Progress in Neuro-Psychopharmacology & Biological Psychiatry 35:1695-1698,
2011.
7. Potvin S, Stip E, Sepehry AA, Gendron A, Bah
R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic
quantitative review. Biological Psychiatry 63: 801-808, 2008.
8. Potvin S., Kouassi E., Lipp O, Bouchard
R.H., Roy, M.A., Demers M.F., Gendron A., Astarita G., Piomelli D., and Stip E.
Endogenous cannabinoids in patients with schizophrenia and substance use
disorder during quetiapine therapy Journal of Psychopharmacology 22: 262-269,
2008.
9. Landau AM, Kouassi E, Siegrist-Johnstone R,
Desbarats J. Unexpected findings in a proteasome inhibition model of
Parkinson's Disease. Movement Disorders 22: 403-407, 2007.
10. Landau AM, Luk KC, Jones ML,
Siegrist-Johnstone R, Young YK, Kouassi E, Rymar VV, Dagher A, Sadikot AF, Desbarats
J. Defective Fas expression exacerbates neurotoxicity in a model of Parkinson's
disease. The Journal of Experimental Medicine 202: 575-581, 2005.
11. Gendron A, Kouassi E, Nuara S, Cossette C,
D'angelo G, Geadah D, du Souich P, Teitelbaum J. Transient middle cerebral
artery occlusion influence on systemic oxygen homeostasis and erythropoiesis in
Wistar rats. Stroke 35: 1979-1984, 2004.
12. Colombo M, Hamelin C, Kouassi E, Fournier M,
Bernier J. Differential effects of mercury, lead, and cadmium on IL-2
production by Jurkat T cells. Clinical Immunology 111: 311-322, 2004.
13. Abdouh M, Albert PR, Drobetsky E, Filep JG,
Kouassi E. 5-HT1A-mediated promotion of mitogen-activated T and B cell survival
and proliferation is associated with increased translocation of NF-kappaB to
nucleus. Brain, Behavior, and Immunity, 18 : 24-34, 2004.
14. Moisan E, Kouassi E, Girard D. Mechanisms
involved in methylmercuric chloride (MeHgCl)-induced suppression of human
neutrophil apoptosis. Human & Experimental Toxicology, 22: 629-637, 2003.
15. Gendron A, Teitelbaum J, Cossette C, Nuara
S, Dumont M, du Souich P, Geadah D, Kouassi E. Temporal effects of left versus
right middle cerebral artery occlusion on spleen lymphocyte subsets and
mitogenic responses in Wistar rats. Brain Research 955: 85-97, 2002.
16. Moisan E, Arbour S, Nguyen N, Hébert MJ,
Girard D, Bernier J., Fournier M, Kouassi E. Prolongation of human neutrophil
survival by low-level mercury via inhibition of spontaneous apoptosis. Journal
of Toxicology and Environmental Health, Part A, 65: 183-203, 2002.
17. Abdouh M, Storring JM, Riad M, Paquette Y,
Albert PR, Drobetsky E, Kouassi E. Transcriptional mechanisms for induction of
5-HT1A receptor mRNA and protein in activated B and T lymphocytes. Journal of
Biological Chemistry 276: 4382-4388, 2001.
18. Goulet AC, Goldmacher VS, Lambert JM, Roy
DC, Baron C, Kouassi E. Conjugation of blocked ricin to an anti-CD19 monoclonal
antibody increases antibody-induced cell calcium mobilization and CD19
internalization. Blood 90: 2364-2375, 1997.
19. Iken K, ChhengS, Fargin A, Goulet AC, Kouassi
E. Serotonin up-regulates mitogen-stimulated B lymphocyte proliferation through
5-HT1A receptors. Cellular Immunology 163: 1-9, 1995.